header("Access-Control-Allow-Origin: *"); ?>
Initial Accreditation Date:May 31 , 2024
Al Dhafra, United Arab Emirates
134808
hassan.hassa@purelab.com
www.purelab.com
Valid Since:Aug 27 , 2025
| Type of Biological Sample | Components / Analytes | Examination Technique | Examination Procedure | Status | |
|---|---|---|---|---|---|
| Biochemistry | |||||
|
|
| PL-CLC-PR-070 | Active | |
|
| PL-CLC-PR-174 | Active | ||
|
| PL-CLC-PR-072 | Active | ||
|
| PL-CLC-PR-105 | Active | ||
|
| PL-CLC-PR-167 | Active | ||
|
| ADH-LW-LAB-SOP-02-113 Version 02 | Active | ||
|
| PL-CLC-PR-180 | Active | ||
| PL-CLC-PR-168 | Active | |||
|
| PL-CLC-PR-123 | Active | ||
|
| ADH·LW-LAB-SOP-02-095 Version 02 | Active | ||
|
| ADH-LW-LAB-SOP-01-123 Version 01 | Active | ||
|
| PL-CLC-PR-108 | Active | ||
|
| ADH-LW-LAB-SOP-02-098 Version 02 | Active | ||
|
| PL-CLC-PR-120 | Active | ||
|
| ADH-LW-LAB-SOP-02-093 Version 02 | Voluntary withdrawal
Since Jul 09, 2026
| ||
| PL-CLC-PR-157 | Active | |||
|
| ADH-LW-LAB-SOP-02-087 Version 02 | Active | ||
|
| ADH-LW-LAB-SOP-04-084 Version 04 | Active | ||
|
| ADH-LW-LAB-SOP-02-085 Version 02 | Active | ||
|
| PL-CLC-PR-171 | Active | ||
|
| ADH-LW-LAB-SOP-02-088 Version 02 | Active | ||
|
| ADH-LW-LAB-SOP-02-093 Version 02 | Active | ||
|
| PL-CLC-PR-109 | Active | ||
|
| ADH-LW-LAB-SOP-04-070 | Active | ||
| ADH-LW-LAB-SOP-04-070 | Active | |||
| ADH-LW-LAB-SOP-04-070 | Active | |||
|
| PL-CLC-IN-008 | Active | ||
|
|
| PL-CLC-PR-173 | Voluntary withdrawal
Since Jul 09, 2026
| |
|
|
| ADH-LW-LAB-SOP-04-063 Version 04 | Active | |
|
| ADH-LW-LAB-SOP-02-113 Version 02 | Voluntary withdrawal
Since Jul 09, 2026
| ||
|
| ADH-LW-LAB-SOP-04-063 Version 04 | Voluntary withdrawal
Since Jun 26, 2026
| ||
| Haematology | |||||
|
|
| PL-HEM-IN-013 | Active | |
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
|
| PL-HEM-IN-013 | Active | ||
| PL-HEM-IN-013 | Active | |||
| PL-HEM-IN-013 | Active | |||
| PL-HEM-IN-013 | Active | |||
|
| PL-HEM-PR-003 | Active | ||
|
|
| ADH-SL-LAB-SOP-04-058 | Active | |
| ADH-SL-LAB-SOP-03-059 | Active | |||
| Immunohematology | |||||
|
|
| ADH-SL-LAB-SOP-01-015 | Active | |
|
| ADH-SL-LAB-SOP-01-017 | Active | ||
| ADH-SL-LAB-SOP-01-018 | Active | |||
| ADH-SL-LAB-SOP-01-016 | Active | |||
| Clinical Pathology | |||||
|
|
| PHL-CLM-PR-002 | Active | |
| PHL-CLM-PR-002 | Active | |||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| PHL-CLM-PR-002 | Active | ||
|
| ADH-SL-LAB-SOP-01-033 | Active | ||
|
|
| PL-CLM-PR-001 | Active | |
| PL-CLM-PR-001 | Active | |||
| PL-CLM-PR-001 | Active | |||
| PL-CLM-PR-001 | Active | |||
| PL-CLM-PR-001 | Active | |||
| PL-CLM-PR-001 | Active | |||
|
| PL-CLM-PR-001 | Active | ||
|
| PL-CLM-PR-011 | Withdrawn
Since Jul 09, 2026
| ||
|
| PL-CLM-PR-022 | Active | ||